Apotransferrin, C1‐esterase inhibitor, and alpha 1‐acid glycoprotein for cerebral protection during experimental hypothermic circulatory arrest

References

• White BC, Sullivan JM, DeGracia DJ, et al. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. J Neurol Sci 2000; 179 Suppl 1-2: 1–31
   PubMed Web of Science ®Google Scholar
• Groenendaal F, Shadid M, McGowan JE, Mishra OP, van Be F. Effects of deferoxamine, a chelator of free iron, on NA(+), K(+)-ATPase activity of cortical brain cell membrane during early reperfusion after hypoxia-ischemia in newborn lambs. Pediatr Res 2000; 48: 560–564.
   Google Scholar
• Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 1994; 25: 1039–1045.
   Google Scholar
• Peeters-Scholte C, Braun K, Koster J, et al. Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res 2003; 54: 516–522.
   Google Scholar
• Prass K, Ruscher K, Karsch M, et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro J Cereb Blood Flow Metab 2002; 22: 520–525.
   Google Scholar
• Liachenko S, Tang P, Xu Y. Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J Cereb Blood Flow Metab 2003; 23: 574–581.
   Google Scholar
• Hernandez LA, Grisham MB, Granger DN. A role for iron in oxidant-mediated ischemic injury to intestinal microvasculature. Am J Physiol 1987; 253 (1 Pt 1): G49–G53.
   Google Scholar
• Sahlstedt L, von Bonsdorff L, Ebeling F, Ruutu T, Parkkinen J. Effective binding of free iron by a single dose of human apotransferrin in hematological stem cell transplant patients. Br J Haematol 2002; 119: 547–551
   PubMed Web of Science ®Google Scholar
• Smith JK, Carden DL, Grisham MB, Granger DN, Korthuis RJ. Role of iron in postischemic microvasculature injury. Am J Physiol 1989; 256 (2 Pt 2): H1472–H1477.
   Google Scholar
• Akita N, Nakase H, Kaido T, Kanemoto Y, Sakaki T. Protective effect of Cl esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 2003; 52: 395–400.
   Google Scholar
• Bergamaschini L, Cicardi M. Recent advances in the use of Cl inhibitor as a therapeutic agent Mol Immunol 2003; 40: 155–158.
   Google Scholar
• Buerke M, Murohara T, Lefer AM. Cardioprotective effects of a Cl esterase inhibitor in myocardial ischemia and reperfusion. Circulation 1995; 91: 393–402.
   Google Scholar
• De Simoni MG, Storini C, Barba M, et al. Neuroprotection by complement (Cl) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab 2003; 23: 232–239.
   PubMed Web of Science ®Google Scholar
• Horstick G, Berg 0, Heimann A, et al. Application of Cl -esterase inhibitor during reperfusion of ischemic myocardium: Dose-related beneficial versus detrimental effects. Circulation 2001; 104: 3125–313L
   Google Scholar
• Nielsen EW, Mollness TE, Harlan JM, Winn RK. Cl-inhibitor reduces the ischemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping. Scand J Immunol 2002; 56: 588–592.
   PubMed Web of Science ®Google Scholar
• Scherer M, Demertzis S, Langer F, Moritz A, Schafers HJ. CI-esterase inhibitor reduces reperfusion injury after lung transplantation. Ann Thorac Surg 2002; 73: 233–238.
   Google Scholar
• Tassani P. Kunkel R, Richter JA, et al. Effect of Cl-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates. J Cardiothorac Vasc Anesth 2001; 15: 469–473.
   PubMed Web of Science ®Google Scholar
• Daemen MA, Heemskerk VH, van't Veer C, et al. Functional protection by acute phase proteins al-acid glycoprotein and al-antitrypsin against ischemia/ reperfusion injury by preventing apoptosis and inflammation. Circulation 2000; 102: 1420–1426.
   Google Scholar
• Bories PN, Kodari E, Feger J, Rouzeau JD, Agneray J, Durand G. A macrophage-derived factor induced by alpha 1-acid glycoprotein that inhibits IL-1 comitogenic activity. Immunol Lett 1990; 26: 105–110.
   PubMed Web of Science ®Google Scholar
• Tilg H, Varmier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: Preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993; 178: 1629–1636.
   Google Scholar
• Vasson MP, Roch-Arveiller M, Couderc R, Baguet JC, Raichvarg D. Effects of alpha-1 acid glycoprotein on human polymorphonuclear neutrophils: Influence of glycan microheterogeneity. Clin Chim Acta 1994; 224: 65–71.
   PubMed Web of Science ®Google Scholar
• Williams JP, Weiser MR, Pechet TTV, Kobzik L, Moore FD Jr, Hechtman HB. al-Acid glycoprotein reduces local and remote injuries after intestinal ischemia in the rat Am J Physiol 1997; 273 (5 Pt 1): GI031–G1035.
   Google Scholar
• Rimpildinen J, Romsi P. Pokela M, et al. Lamotrigine plus leukocyte filtration as a neuroprotective strategy in experimental hypothermic circulatory arrest. Ann Thorac Surg 2002; 73: 163–172.
   PubMed Web of Science ®Google Scholar
• Rimpildinen J, Pokela M, Kiviluoma K, et al. The N-methyl-D-aspartate antagonist memantme has no neuroprotective effect during hypothermic circulatory arrest: A study in the chronic porcine model. J Thorac Cardiovasc Surg 2001; 121: 957–968.
   PubMed Web of Science ®Google Scholar
• Romsi P. Kaakinen T, Kiviluoma K, et al. Fructose-1,6-bisphosphate for improved outcome after hypothermic circulatory arrest in pigs. J Thorac Cardiovasc Surg 2003; 125: 686–698.
   PubMed Web of Science ®Google Scholar
• Pokela M, Dahlbacka S, Biancari F, et al. pH-stat vs. alpha-stat perfusion strategy during experimental hypothermic circulatory arrest. A microdialysis study. Ann Thorac Surg 2003; 76: 1215–1226.
   Google Scholar